MedTrace Logo

Low-volume Polyethylene Glycol Bowel Preparation for Colonoscopy

NCT01929590 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2013-08-28

No results posted yet for this study

Summary

the efficacy and tolerability of a low-volume (2 L) PEG regimen for colonoscopy compared to single (4 L) or split-dose (2 L + 2 L) treatments are not different.

Conditions

  • Bowel Preparation for Colonoscopy

Interventions

DRUG

PEG-3350 group 2

split-dose (PEG-3350; 2 L the day before 17:00-19:00 h and 2 L same day of the procedure 06:00-08:00 am)

DRUG

PEG-3350 group 1

PEG-3350; PEG-4 L the day previous of the study, starting at 17:00 and finishing at 21:00 h

DRUG

PEG-3350 group 3

low-volume 2 L PEG-solution (same day of the procedure 06:00-08:00 am)

Sponsors & Collaborators

  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

    lead OTHER

Principal Investigators

  • Felix Téllez-Ávila, Ph.D. · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01929590 on ClinicalTrials.gov